Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors. European Organization for Research and Treatment of Cancer Early Clinical Studies Group.Ferry A.L.M. Eskens, U. Bruntsch, Denis Lj et al.|PubMed|2000Cited by 25
Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days.Ingmar Wolff, Cristiana Sessa, K Bench et al.|PubMed|1996Cited by 16